- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
27 result(s) found for: Histidine.
Displaying page 1 of 2.
EudraCT Number: 2012-001112-29 | Sponsor Protocol Number: CL-N-HTX-CSM-III/04/12 | Start Date*: 2015-07-27 |
Sponsor Name:Dr. Franz Köhler Chemie GmbH | ||
Full Title: A Prospective, randomized, single blind, multicenter Phase III study of organ perfusion with Custodiol-N solution compared with Custodiol solution in Heart transplantation | ||
Medical condition: Patients that has to undergo (is suitable for) a heart transplantation | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-002329-56 | Sponsor Protocol Number: FISIO | Start Date*: 2021-10-19 | |||||||||||
Sponsor Name:Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC) | |||||||||||||
Full Title: Exploratory study to evaluate the efficacy and safety of nutritionally administering 1.5 g protein/kg/day vs. 1.0 g protein/kg/day in the catabolic phase of the critically ill patient on mechanical... | |||||||||||||
Medical condition: Acquired Weakness in the Intensive Care Unit (DAUCI) of the critically ill patient. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012602-39 | Sponsor Protocol Number: 05-NEOV-002 | Start Date*: 2010-05-17 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: A randomised, double-blind study evaluating the safety, tolerability, protein accretion, amino acid plasma levels and long-term outcome of Neoven compared to Vaminolact(R) in premature very low bir... | |||||||||||||
Medical condition: The product is aimed to be used where parenteral nutrition is required. The intended indication is: Supply of essential and non-essential amino acids as part of parenteral nutrition for premature ... | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012604-92 | Sponsor Protocol Number: 05-NEOV-004 | Start Date*: 2010-04-19 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: A randomised, double-blind study of the safety and efficacy of Neoven compared to Vaminolact in infants and children requiring long-term parenteral nutrition | |||||||||||||
Medical condition: The product is aimed to be used where parenteral nutrition is required. The intended indication is: Supply of essential and non-essential amino acids as part of Parenteral Nutrition for infants an... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002198-20 | Sponsor Protocol Number: CLNKLPTXIII07AT17 | Start Date*: 2018-11-28 |
Sponsor Name:Dr. Franz Köhler Chemie GmbH | ||
Full Title: A Prospective, randomized, single blind, multicentre Phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in organ transplantation (kidney, liver and pan... | ||
Medical condition: patients who will undergo kidney, liver or kidney-pancreatic transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012603-26 | Sponsor Protocol Number: 05-NEOV-003 | Start Date*: 2010-04-08 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH [...] | |||||||||||||
Full Title: A randomised, double-blind study evaluating the safety, tolerability and clinical outcome of Neoven compared to Vaminolact in premature ELBW infants | |||||||||||||
Medical condition: The product is aimed to be used where parenteral nutrition is required. The intended indication is: Supply of essential and non-essential amino acids as part of Parenteral Nutrition for premature ... | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Prematurely Ended) FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001872-12 | Sponsor Protocol Number: CL-N-LTX-III/08-ESP/19 | Start Date*: 2021-12-28 | |||||||||||||||||||||
Sponsor Name:Dr. Franz Köhler Chemie GmbH | |||||||||||||||||||||||
Full Title: A Prospective, randomized, single blind, multicenter Phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in liver transplantation | |||||||||||||||||||||||
Medical condition: Liver transplantation. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011022-33 | Sponsor Protocol Number: 112993 | Start Date*: 2009-05-06 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: A phase II, double-blind study to evaluate the safety, reactogenicity and immunogenicity of two different formulations of GSK Biologicals’ pneumococcal protein candidate vaccine, when given as a b... | ||
Medical condition: Booster vaccination with a pneumococcal protein candidate vaccine in healthy young adults aged between 18 and 41 years old, previously primed with 2 doses of pneumococcal protein vaccine in study S... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-001795-34 | Sponsor Protocol Number: CL-N-HTX-Paed-II/10/20 | Start Date*: 2023-01-30 | |||||||||||
Sponsor Name:Dr. Franz Köhler Chemie GmbH | |||||||||||||
Full Title: A prospective randomized single blind multicenter phase II study of organ perfusion with Custodiol-N compared with Custodiol in heart transplantation in children | |||||||||||||
Medical condition: Preservation of hearts prior to heart transplantation in children | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000429-20 | Sponsor Protocol Number: 05-NEOV-001 | Start Date*: 2008-10-17 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: A randomised, double-blind study evaluating the safety, tolerability, and amino acid plasma levels of Neoven compared to Vaminolact in infants after surgical interventions. | |||||||||||||
Medical condition: The product is aimed to be used where parenteral nutrition is required. The indended indication is: Supply of essential and non-essential amino acids as part of parenteral nutrition for preterm an... | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) BE (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003776-40 | Sponsor Protocol Number: CL-N-CSM-AV-III/05/12 | Start Date*: 2013-11-08 |
Sponsor Name:Dr. Franz Köhler Chemie GmbH | ||
Full Title: A Prospective Randomized Double Blind Multicenter Phase III Study Comparing two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N versus Custodiol | ||
Medical condition: Patients with aortic valve disease and has to undergo aortic valve surgery +/- bypass surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-005503-13 | Sponsor Protocol Number: 1.0_Custodiol | Start Date*: 2015-02-16 | |||||||||||
Sponsor Name:Essen University Hospital, University of Essen, Klinik für Allgemein-, Viszeral- und Transplantationschirugie | |||||||||||||
Full Title: A prospective randomized single blind monocenter phase II study of organ perfusion with Custodiol-N compared with Custodiol solution in living donor kidney transplantation | |||||||||||||
Medical condition: kidney preservation by Custodiol-N or Custodiol solution before living related kidney transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000342-19 | Sponsor Protocol Number: IIT-2017/02 | Start Date*: 2018-10-18 |
Sponsor Name:Otto-von-Guericke-Universität Magdeburg, Medizinische Fakultät | ||
Full Title: Prospective, randomized, double-blind clinical trial phase II for the anti-inflammatory effects of Curazink (zinc histidine) for 8 weeks in elderly patients with mild cognitive impairment in Alzhei... | ||
Medical condition: Included are patients with the presence of a moderate or pronounced zinc deficienc and the diagnosis of a mild cognitive disorder, which may be due to an additional investigation (amyloid PET and /... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-006153-31 | Sponsor Protocol Number: CSC/P01/07/Mu.F | Start Date*: 2008-04-23 | |||||||||||
Sponsor Name:Baxter R and D Europe SCRL | |||||||||||||
Full Title: Safety and efficacy of subcutaneous (SC) administration of Clinimix N9G15E in elderly patients at risk for malnutrition, at a dose of 1 liter infused over 12 hours for 7 to 10 consecutive days. A p... | |||||||||||||
Medical condition: The population studied will be the elderly population at risk for malnutrition without any predefined pathology at hospital geriatrician wards. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012701-19 | Sponsor Protocol Number: 113171 | Start Date*: 2009-10-15 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: A phase II, randomized, controlled, observer-blind study to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ Streptococcus pneumoniae protein containing va... | ||
Medical condition: Two-dose primary vaccination of healthy children between 12 and 23 months of age at the time of the first vaccination against Streptococcus pneumoniae (S pneumoniae) and Haemophilus influenzae (H. ... | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-005325-39 | Sponsor Protocol Number: ELX-NPP-2016-01 | Start Date*: 2016-04-26 | |||||||||||
Sponsor Name:Dr. Antonio Arroyo Sebastián | |||||||||||||
Full Title: A RANDOMIZED, CONTROLLED, CLINICAL TRIAL TO COMPARE PERIPHERAL PARENTERAL NUTRITION (PeriOlimel N4-E) VS CONVENTIONAL FLUID THERAPY IN ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL IN COLORECTAL ... | |||||||||||||
Medical condition: Cancer colorectal | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-006290-25 | Sponsor Protocol Number: 4141 | Start Date*: 2012-05-03 |
Sponsor Name:Copenhagen University Hospital Rigshospitalet, The Heart Center - Department of Thoracic Surgery | ||
Full Title: The Pulmonary Protection Trial (PP-Trial) Pulmonary dysfunction after open heart surgery: Randomized clinical trial with focus on lung-protective interventions | ||
Medical condition: Dysfunction of the lungs after open heart surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-009918-40 | Sponsor Protocol Number: LG-TAU-2008-04 | Start Date*: 2009-07-22 | |||||||||||
Sponsor Name:LABORATORIOS GRIFOLS, S.A. | |||||||||||||
Full Title: Ensayo Clínico fase IV, prospectivo, aleatorizado, doble ciego, de grupos paralelos y unicéntrico, para evaluar el efecto de la taurina en Nutrición Parenteral Total sobre la función hepática en pa... | |||||||||||||
Medical condition: Evaluar el efecto de la taurina en nutrición Parenteral Total sobre la función hepática en pacientes postquirúrgicos. Evaluate the effect of taurine in Total Parenteral Nutrition on the hepatic fun... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005992-81 | Sponsor Protocol Number: CL-N-CSM-III/01/08 | Start Date*: 2011-03-21 | |||||||||||
Sponsor Name:Dr. F. Köhler Chemie GmbH | |||||||||||||
Full Title: A Prospective Randomized Double Blind Multicenter Phase III Study Comparing two Methods of Cardioplegia in Coronary Artery Bypass Surgery Custodiol-N versus Custodiol | |||||||||||||
Medical condition: The study population will be selected from both genders with coronary artery disease (CAD) who are to undergo cardiopulmonary bypass for coronary artery bypass surgery. The ratio of incidence for b... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002183-27 | Sponsor Protocol Number: T-019 | Start Date*: 2013-04-03 | |||||||||||
Sponsor Name:Hammersmith Medicines Research | |||||||||||||
Full Title: Can netazepide eradicate the inflammatory response of the gastric mucosa to H. pylori infection? | |||||||||||||
Medical condition: Gastritis associated with H. pylori infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.